Cleared Abbreviated

K080853 - DUO-CARE BLOOD GLUCOSE AND BLOOD PRESSURE MONITOR SYSTEM

K080853 is an FDA 510(k) clearance for DUO-CARE BLOOD GLUCOSE AND BLOOD PRESSU..., manufactured by Genexel-Sein, Inc.. The device is a Class 2 Chemistry device with product code NBW cleared through the Abbreviated 510(k) pathway after a 331-day FDA review.

K080853 · Genexel-Sein, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2009
Decision
331d
Days
Class 2
Risk

K080853 is an FDA 510(k) clearance for the DUO-CARE BLOOD GLUCOSE AND BLOOD PRESSURE MONITOR SYSTEM. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Genexel-Sein, Inc. (Roswell, US). The FDA issued a Cleared decision on February 20, 2009 after a review of 331 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Genexel-Sein, Inc. devices

FDA 510(k) Submission Details - K080853

510(k) Number K080853 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 26, 2008
Decision Date February 20, 2009
Days to Decision 331 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
243d slower than avg
Panel avg: 88d · This submission: 331d
Pathway characteristics
Standards-based clearance path.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 459
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K080853.
TRUEBALANCE BLOOD GLUCOSE SYSTEM
K090495 · Home Diagnostics, Inc. · Mar 2009
FORA V12 NO-CODING BLOOD GLUCOSE MONITORING SYSTEM, MODEL TD-4247
K090536 · Taidoc Technology Corporation · Mar 2009
BETACHEK GLUCOSE TEST
K062187 · National Diagnostic Products · Mar 2009
G5 INFINITY BLODO GLUCOSE MONITORING SYSTEM WITH MODEL IGM, 0024A
K082201 · U. S. Diagnostics, Inc. · Feb 2009
CARESENS N BLOOD GLUCOSE MONITORING SYSTEM, CARESENS N METER, MODEL GM5051A OR GM5051B OR GM5051C (COLOR)
K083468 · I-Sens, Inc. · Feb 2009
EASYPLUS MINI R2N SELF MONITORING GLUCOSE TEST SYSTEM
K081796 · Eps Bio Technology Corp. · Jan 2009